XML 84 R55.htm IDEA: XBRL DOCUMENT
v3.24.1

Group Information - Summary of Information about Subsidiaries (Details) | 12 Months Ended
--- | ---
Dec. 31, 2023 | Dec. 31, 2022
BioNTech BioNTainer Holding GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Cell & Gene Therapies GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Delivery Technologies GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Diagnostics GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Europe GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Idar-Oberstein Services GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Individualized mRNA Manufacturing GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Innovation and Services Marburg GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Innovation GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Innovative Manufacturing Services GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Manufacturing GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Manufacturing Marburg GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Real Estate Holding GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Real Estate Verwaltungs GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
InstaDeep DE GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% |
JPT Peptide Technologies GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
NT Security and Services GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
reSano GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Australia Pty Ltd. |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech R&D (Austria) GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech (Shanghai) Pharmaceuticals Co. Ltd. |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
InstaDeep France SAS |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% |
Biopharma BioNTech Israel Ltd. |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% |
New Technologies Re​ |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% |
InstaDeep Nigeria Limited |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% |
BioNTech Rwanda Ltd. |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Sénégal Suarl |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% |
BioNTech Pharmaceuticals Asia Pacific Pte. Ltd. |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Pharmaceuticals Spain S.L |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% |
BioNTech Switzerland GmbH |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% |
BioNTech Taiwan Co. Ltd. |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% |
InstaDeep Tunisia SARL |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% |
BioNTech Turkey Tıbbi Ürünler Ve Klinik Araştirma Ticaret Anonim Şirketi |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech UK Ltd. |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
InstaDeep Ltd. |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 530.00%
BioNTech Research and Development, Inc. |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech USA Holding, LLC |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech US Inc. |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%
BioNTech Delivery Technologies (US), LLC |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% |
InstaDeep LLC |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% |
JPT Peptide Technologies Inc. |  |
Disclosure of subsidiaries [line items] |  |
% equity interest | 100.00% | 100.00%

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2023-01-01 -Paragraph 17 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_iii&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2023-01-01 -Paragraph 16 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_iii&doctype=Standard -URIDate 2023-03-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2023-01-01 -Paragraph 19B -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_c&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ProportionOfOwnershipInterestInSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechBioNTainerHoldingGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechCellGeneTherapiesGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechDeliveryTechnologiesGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechDiagnosticsGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechEuropeGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechIdarObersteinServicesGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechIndividualizedMRNAManufacturingGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechInnovationAndServicesMarburgGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechInnovationGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechInnovativeManufacturingServicesGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechManufacturingGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechManufacturingMarburgGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechRealEstateHoldingGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechRealEstateVerwaltungsGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_InstaDeepDEGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_JPTPeptideTechnologiesGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_NTSecurityAndServicesGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_ReSanoGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechAustraliaPtyLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechRDAustriaGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechShanghaiPharmaceuticalsCo.Ltd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_InstaDeepFranceSASMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BiopharmaBioNTechIsraelLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_NewTechnologiesReMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_InstaDeepNigeriaLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechRwandaLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechSenegalSuarlMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechPharmaceuticalsAsiaPacificPte.Ltd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechPharmaceuticalsSpainS.LMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechSwitzerlandGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechTaiwanCo.Ltd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_InstaDeepTunisiaSARLMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechTurkeyTbbiUrunlerVeKlinikArastirmaTicaretAnonimSirketiMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechUKLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_InstaDeepLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechResearchAndDevelopmentInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechUSAHoldingLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechUSInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_BioNTechDeliveryTechnologiesUSLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_InstaDeepLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=bntx_JPTPeptideTechnologiesInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |